Company News
Emcure Acquires Full 100% Ownership of Gennova Biopharmaceuticals
Emcure Pharmaceuticals acquires remaining 12.05% stake in Gennova Biopharmaceuticals to make it a wholly owned subsidiary.
Leadership transition places Samit Mehta as CEO of Gennova to focus on biolog
